Skip to content
Diacerein
Diacerein is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
M: Musculo-skeletal system drugs
— M01: Antiinflammatory and antirheumatic products
— M01A: Antiinflammatory and antirheumatic products, non-steroids
— M01AX: Other antiinflammatory and antirheumatic agents, non-steroids in atc
— M01AX21: Diacerein
HCPCS
No data
Clinical
Clinical Trials
32 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteoarthritisD010003EFO_0002506M15-M19——1416
Knee osteoarthritisD020370EFO_0004616M17——23—5
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E11—41——5
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81——1——1
Hip osteoarthritisD015207EFO_1000786M16——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Epidermolysis bullosaD004820Q8112———3
Epidermolysis bullosa simplexD016110Q81.012———3
ThrombocytopeniaD013921HP_0001873D69.6—2———2
Diabetes complicationsD048909—2———2
Diabetes mellitusD003920EFO_0000400E08-E13—1———1
Insulin resistanceD007333EFO_0002614—1———1
GoutD006073EFO_0004274M10—1———1
ObesityD009765EFO_0001073E66.9—1———1
OverweightD050177E66.3—1———1
Bullous pemphigoidD010391EFO_0007187L12—1———1
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—4————4
Epidermolysis bullosa dystrophicaD016108Q81.21————1
Junctional epidermolysis bullosaD016109Q81.11————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIACEREIN
INNdiacerein
Description
4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O
Identifiers
PDB—
CAS-ID13739-02-1
RxCUI22759
ChEMBL IDCHEMBL41286
ChEBI ID—
PubChem CID26248
DrugBankDB11994
UNII ID4HU6J11EL5 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,091 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
82 adverse events reported
View more details